Does FILGRASTIM Cause Second primary malignancy? 32 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Second primary malignancy have been filed in association with FILGRASTIM (NYPOZI txid). This represents 0.2% of all adverse event reports for FILGRASTIM.
32
Reports of Second primary malignancy with FILGRASTIM
0.2%
of all FILGRASTIM reports
23
Deaths
3
Hospitalizations
How Dangerous Is Second primary malignancy From FILGRASTIM?
Of the 32 reports, 23 (71.9%) resulted in death, 3 (9.4%) required hospitalization, and 4 (12.5%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FILGRASTIM. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does FILGRASTIM Cause?
Off label use (1,930)
Febrile neutropenia (1,570)
Neutropenia (1,431)
Death (1,213)
Pyrexia (1,085)
Diarrhoea (739)
Nausea (718)
Bone pain (706)
Thrombocytopenia (697)
Anaemia (626)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which FILGRASTIM Alternatives Have Lower Second primary malignancy Risk?
FILGRASTIM vs FILGRASTIM-AAFI
FILGRASTIM vs FILGRASTIM-SNDZ
FILGRASTIM vs FINASTERIDE
FILGRASTIM vs FINASTERIDE\TAMSULOSIN
FILGRASTIM vs FINERENONE